본문 바로가기 주메뉴 바로가기
  • HOME
  • Business Info
  • Immuncell-LC
  • Product Info

Business Info

Immuncell-LC

  • Immuncell-LC(이뮨셀-엘씨) 사진
  • Immuncell-LC(이뮨셀-엘씨) 사진
  • Immuncell-LC(이뮨셀-엘씨) 사진
  • Immuncell-LC(이뮨셀-엘씨) 사진
  • Immuncell-LC(이뮨셀-엘씨) 사진
  • Immuncell-LC(이뮨셀-엘씨) 사진
  • Immuncell-LC(이뮨셀-엘씨) 사진 썸네일
  • Immuncell-LC(이뮨셀-엘씨) 사진 썸네일
  • Immuncell-LC(이뮨셀-엘씨) 사진 썸네일
  • Immuncell-LC(이뮨셀-엘씨) 사진 썸네일
  • Immuncell-LC(이뮨셀-엘씨) 사진 썸네일
  • Immuncell-LC(이뮨셀-엘씨) 사진 썸네일

The drug is categorized as ‘prescription drugs’ by MFDS. It needs consultation with healthcare professionals and doctors who can make accurate judgements about efficacy and adverse events.

Immuncell-LC(이뮨셀-엘씨) 정보입니다.
Efficacy·Effect Adjuvant therapy for patients whose tumor has been removed after curative resection for Hepatocellular Carcinoma (Operation, Radio Frequency Ablation, Percutaneous Ethanol Injection Therapy)
Dosage and
Administration
  • 1. Mix the settled cells and suspension fluid three or four times prior to administration.
  • 2. Use an 22G needle or larger bore one for an intravenous infusion, and be sure that the administration is completed within one hour.
  • 3. The dose of administration for each time is 200 ㎖ over a spot that contains 1x109 ~ 2x1010 cells.
  • 4. The interval and times of administration are as follows: 4 times, once a week, 4 times, once every two weeks, 4 times, once every four weeks, 4 times, once every eight weeks 16 times in total .
Storage Sealed container at temperature of 2 - 25℃
Expiration
  • 24 hours from time of manufacture